As ranked in the top 5 generic pharmaceutical producers in Turkey, Deva Holding S.A. initiated a restructuring process to adopt a new face and vision. In this respect, as Deva we want to widen up our product portfolio adding new compounds such as oncology, cardiovascular, and antidepressant agents while strengthening its expertise already acknowledged in various fields of medicine. Therefore, we search for opportunities to embody long term partnership to have access to constant supply of either API and/or finished product and its dossier together.

Since the Turkish Pharmaceutical Market has grown nearly 10 % in the last decade, we realize the importance of the strong licensing partnership to stabilize and strengthen our ground. In conjunction with this, we at Deva Holding S.A. look for the best possible option in regard to finding what we look for in a product line. We build our business alliances structured based upon the need and interest of the company regarding to the market situation. We do not establish partnership with only one particular company and in fact we are in close contact with the generic pharmaceutical companies from EU, India, and Pacific countries, which demonstrates the diversity in our partners.

We launched 10 products as a result of the concerted efforts over a period of only 12 months. This is the success of the whole team consisted of many departments including Business Development, Marketing, Purchasing, and Intellectual Property Rights.

For further information please contact our Business Development Department:

           Phone: +90 212 692 94 09
           Fax    : +90 212 697 23 10